Eventide Healthcare & Life Sciences Fund CLASS C SHARES (ETCHX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
43.98
-0.23 (-0.52%)
At close: Feb 13, 2026
Fund Assets1.64B
Expense Ratio2.32%
Min. Investment$1,000
Turnover41.00%
Dividend (ttm)n/a
Dividend Yieldn/a
Dividend Growthn/a
Payout Frequencyn/a
Ex-Dividend Daten/a
Previous Close44.21
YTD Return-3.04%
1-Year Return42.24%
5-Year Return-8.08%
52-Week Low23.58
52-Week High46.49
Beta (5Y)n/a
Holdings74
Inception DateDec 27, 2012

About ETCHX

Eventide Healthcare & Life Sciences Fund Class C Shares is a mutual fund that primarily invests in companies operating within the healthcare and life sciences sectors. The fund seeks to achieve long-term capital appreciation by allocating at least 80% of its net assets to equity and equity-related securities of businesses involved in areas such as pharmaceuticals, biotechnology, medical devices, healthcare services, and life science tools. Its portfolio commonly includes both established and emerging firms engaged in innovation across the healthcare landscape, such as drug development, diagnostics, and therapeutics. The fund is actively managed and often holds a concentrated allocation in its top holdings, reflecting a targeted investment approach within its specialized sector. Designed for investors seeking focused exposure to the dynamic healthcare industry, this fund navigates a high-risk, high-reward environment, given the sector’s sensitivity to regulatory changes, research breakthroughs, and market competition. The fund’s Class C shares feature a higher ongoing expense ratio and are suited to investors with a relatively shorter investment horizon due to their fee structure. Overall, the fund plays a significant role in diversifying portfolios with sector-specific growth potential and access to the innovations driving healthcare advancements.

Fund Family Eventide Funds
Category Health
Performance Rating Below Average
Risk Rating High
Stock Exchange NASDAQ
Ticker Symbol ETCHX
Share Class Class C Shares
Index S&P Biotechnology Select Industry TR

Performance

ETCHX had a total return of 42.24% in the past year, including dividends. Since the fund's inception, the average annual return has been 16.59%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
ETIHXClass I Shares1.32%
ETNHXClass N Shares1.52%
ETAHXClass A Shares1.57%

Top 10 Holdings

41.35% of assets
NameSymbolWeight
Insmed IncorporatedINSM6.18%
Mirum Pharmaceuticals, Inc.MIRM5.88%
US BANK MMDA - USBGFS 9n/a4.67%
Guardant Health, Inc.GH4.48%
Celcuity Inc.CELC4.00%
Scholar Rock Holding CorporationSRRK3.67%
Axsome Therapeutics, Inc.AXSM3.50%
Alnylam Pharmaceuticals, Inc.ALNY3.42%
iRhythm Holdings, Inc.IRTC2.85%
Kymera Therapeutics, Inc.KYMR2.71%
View More Holdings